NCT05456087: Use of Botulinum Toxin in the Treatment of Androgenic Alopecia
- State
- Under way
- Phase
- Phase 2
- People
- 20 taking part
- Started
- 12 Aug 2022
- Primary completion
- Dec 2024
- Arms
- Single treatment with Xeomin® (incobotulinumtoxin A)
- Results
- None posted
- 13 Jul 2022: Trial registered
- 12 Aug 2022: Trial started